TY - JOUR
T1 - Effect of Sorbitol on Psychomotor Function
T2 - Its Use in Alcoholic Cirrhosis
AU - Mcclain, Craig J.
AU - Kromhout, James P.
AU - Zieve, Leslie
AU - Duane, William C
PY - 1981/6
Y1 - 1981/6
N2 - Sorbitol solution has been used as a control substance in evaluating the efficacy of lactulose therapy for hepatic encephalopathy (HE). However, recent in vitro studies suggested that sorbitol may not be an inert placebo and may have therapeutic relevance. We evaluated in vivo metabolism of sorbitol in healthy volunteers and alcoholic cirrhotic patients and found that sorbitol was metabolized by gut bacteria in a similar manner to lactulose. We next evaluated the effect of sorbitol treatment on five psychomotor performance tests in cirrhotic patients. Patients receiving sorbitol demonstrated improvement in all psychomotor tests, whereas similar patients not receiving sorbitol showed no improvement. We conclude the following: sorbitol is metabolized by gut bacteria in man, sorbitol therapy improved psychomotor performance in cirrhotic patients, and previous studies using sorbitol as a control underestimated the beneficial effects of lactulose.
AB - Sorbitol solution has been used as a control substance in evaluating the efficacy of lactulose therapy for hepatic encephalopathy (HE). However, recent in vitro studies suggested that sorbitol may not be an inert placebo and may have therapeutic relevance. We evaluated in vivo metabolism of sorbitol in healthy volunteers and alcoholic cirrhotic patients and found that sorbitol was metabolized by gut bacteria in a similar manner to lactulose. We next evaluated the effect of sorbitol treatment on five psychomotor performance tests in cirrhotic patients. Patients receiving sorbitol demonstrated improvement in all psychomotor tests, whereas similar patients not receiving sorbitol showed no improvement. We conclude the following: sorbitol is metabolized by gut bacteria in man, sorbitol therapy improved psychomotor performance in cirrhotic patients, and previous studies using sorbitol as a control underestimated the beneficial effects of lactulose.
UR - http://www.scopus.com/inward/record.url?scp=0019445613&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0019445613&partnerID=8YFLogxK
U2 - 10.1001/archinte.1981.00340070081017
DO - 10.1001/archinte.1981.00340070081017
M3 - Article
C2 - 7235810
AN - SCOPUS:0019445613
SN - 0003-9926
VL - 141
SP - 901
EP - 903
JO - Archives of Internal Medicine
JF - Archives of Internal Medicine
IS - 7
ER -